anti cancer drug articles & resources on Made-in-China.com

Clinical Trials Investigating New Uses Have Produced Mixed Results

Feb 19, 2014

Clinical trials investigating new uses for the anti-cancer drug Avastin have produced mixed results. When combined with standard chemotherapy, Avastin extended the survival of patients with advanced cervical cancer by nearly four months, ...

Tags: Health, Medicine

Novogen Has Announced The Filing of a Family of Provisional Patents in The US

Nov 29, 2013

Novogen, a biotechnology company, has announced the filing of a family of provisional patents in the US covering anti-tropomyosin (ATM) drug technology. ATM drugs represent an entirely novel approach to anti-cancer therapy, blocking the ...

Tags: Health, Medicine, Anti-Tropomyosin Drug Technology

CRT Has Collaborated with Danish Drug Discovery Firm Nuevolution to Develop Cancer Drugs

Nov 6, 2013

Cancer Research UK's commercial arm Cancer Research Technology (CRT) has collaborated with Danish drug discovery firm Nuevolution for the discovery of anti-cancer drug molecules targeting several key proteins. The deal is aimed at ...

Tags: Cancer Drugs, Medicine

IPAB Cancelled The Patent for GSK's Anti-Cancer Drug Tykerb

Aug 6, 2013

The Intellectual Property Appellate Board (IPAB) in India has cancelled the patent for GlaxoSmithKline's (GSK) anti-cancer drug Tykerb in its salt form over failure in demonstrating significant improvement in the efficacy. Fresenius ...

Tags: Anti-Cancer Drug

Curis Announced The Approval of Erivedge for Treatment of Metastatic Basal Cell Carcinoma

May 14, 2013

Oncology-focused company Curis has announced the approval of Erivedge (vismodegib) in Australia for the treatment of metastatic basal cell carcinoma, or with locally advanced basal cell carcinoma in adult patients who are not suitable for ...

Tags: Curis, Erivedge Anti-Cancer Drug

Indian Supreme Court Rejected Novartis' Patent Application for Its Anti-Cancer Drug Glivec

Apr 2, 2013

The Indian Supreme Court has rejected Novartis' patent application for its anti-cancer drug Glivec (imatinib mesylate) saying that “application for patent on the beta-crystalline salt does not meet any standard of novelty or ...

Tags: Indian Apex, Novartis'Patent Plea, Glivec

EC Granted Conditional Marketing Authorization for Bosutinib Anti-Cancer Drug in The EC

Apr 1, 2013

The European Commission (EC) has granted conditional marketing authorization for Pfizer's Bosulif (bosutinib) anti-cancer drug in the European Union (EU). Bosulif is authorized in Europe for the treatment of adult patients with chronic ...

Tags: Pfizer Bosulif, cancer drug, drug

Ablynx Has Signed an Agreement with Spirogen to Evaluate Novel Anti-Cancer Drug Conjugate

Feb 26, 2013

Ablynx has signed a collaborative agreement with Spirogen to evaluate the potential of a novel anti-cancer drug conjugate. As part of the deal, both the firms will evaluate anti-cancer drug conjugate by using Spirogen's proprietary ...

Tags: Ablynx inks, anti cancer drug, drug

Saladax Biomedical Has Signed a Diagnostic Agreement

Nov 30, 2012

Saladax Biomedical has signed a diagnostic agreement with Eilaf Pharma for My5-FU diagnostic test in Egypt and throughout the Middle East North African (MENA) region. The test will measure the levels of an anti-cancer drug, ...

Tags: My5-FU diagnostic test, medical research, medical test

TTY Biopharm Inaugurated a Drug Factory in Suzhou

Nov 29, 2012

TTY Biopharm Co.,Ltd.,a major pharmaceutical maker in Taiwan,recently inaugurated a drug factory in Suzhou,Jiangsu Province of China,operated by TTY`s Chinese subsidiary TOT Biopharm Co.,Ltd. At a cost of about US$100 million,the factory ...

Tags: TTY Biopharm, drug factory, anti-cancer drug injections, Suzhou

ACT Received Phase I SBIR Grant of $158,000 From NIH to Support Drug Development

Nov 28, 2012

Advanced Cancer Therapeutics (ACT) has received Phase I small business innovative research (SBIR) grant of $158,000 from the National Cancer Institute of the National Institutes of Health (NIH) to support the development of an anti cancer ...

Tags: ACT, SBIR Grant, anti cancer drug, Anticancer Drug

Tocagen Has Entered Into a Partnership Agreement with MRI Interventions and Brainlab

Nov 27, 2012

Clinical stage biopharmaceutical company, Tocagen, has entered into a partnership agreement with MRI Interventions and Brainlab. Under the collaboration, Tocagen will use MRI Interventions' ClearPoint neuro intervention system at selected ...

Tags: Tocagen, Medicine

As Gliomas,Results Are Interesting for Treating Skin Cancer

Sep 5, 2012

Results are interesting for treating skin cancer(melanoma)and nervous system tumors,known as gliomas. "Promising results"-Pablo Botella,researcher at the Institute of Chemical Technology of Valencia. Spanish researchers have ...

Tags: laser, cancer, treatment, gliomas

anti cancer drug

Related Products